openPR Logo
Press release

Investigation announced for NASDAQ: AXSM Investors over possible Wrongdoing at Axsome Therapeutics, Inc.

09-20-2022 02:10 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares.

An investigation on behalf of current long term investors in Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares.

An investigation was announced for clong-term investors in shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) concerning potential breaches of fiduciary duties by certain directors and officers of Axsome Therapeutics, Inc.

Investors who are current long term investors in Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: AXSM stocks follows a lawsuit filed against Axsome Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: AXSM stocks, concerns whether certain Axsome Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose that Axsome's CMC practices were deficient with respect to AXS-07 and its manufacturing process, that as a result, Axsome was unlikely to submit the AXS-07 NDA on its initially represented timeline, that the foregoing CMC issues remained unresolved at the time that the FDA reviewed the AXS-07 NDA, that accordingly, the FDA was unlikely to approve the AXS-07 NDA, that as a result of all the foregoing, Axsome had overstated AXS-07's regulatory and commercial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for NASDAQ: AXSM Investors over possible Wrongdoing at Axsome Therapeutics, Inc. here

News-ID: 2740474 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Axsome

Smoking Cessation and Nicotine Addiction Pipeline Analysis 2025 by DelveInsight …
DelveInsight's, "Smoking Cessation and Nicotine Deaddiction - Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Smoking Cessation and Nicotine Deaddiction pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. DelveInsight's analysis shows that the Smoking Cessation and Nicotine Addiction pipeline involves over 5
Axsome Therapeutics, Inc. (NASDAQ: AXSM) Long Term Investor Notice: Lawsuit agai …
An investor in shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) filed a lawsuit against certain directors of Axsome Therapeutics, Inc. over alleged breaches of fiduciary duties. Investors who are current long term investors in Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The lawsuit against certain directors comes after a lawsuit was filed against Axsome Therapeutics, Inc.
Deadline on July 12, 2022 coming up in Lawsuit for Investors in Axsome Therapeut …
A deadline is coming up on July 12, 2022 in the lawsuit filed for certain investors of Axsome Therapeutics, Inc. (NASDAQ: AXSM) over alleged securities laws violations by Axsome Therapeutics, Inc. Investors who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and there are strict and short deadlines running. Deadline: July 12, 2022. NASDAQ: AXSM stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for Investors in shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM …
An investor, who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Axsome Therapeutics, Inc. Investors who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and for certain investors are short and strict deadlines running. Deadline: July 12, 2022. NASDAQ: AXSM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. New
Investigation announced for Long-Term Investors in Axsome Therapeutics, Inc. (NA …
Certain directors of Axsome Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Axsome Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders. New York based Axsome Therapeutics,
Investigation announced for Investors in shares of Axsome Therapeutics, Inc. (NA …
An investigation was announced over potential securities laws violations by Axsome Therapeutics, Inc. in connection with certain financial statements. Investors who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Axsome Therapeutics, Inc. regarding its business, its prospects and its operations were